Dr. Karine Cohen-Solal is an oncologist with leading expertise in melanoma, having directed a laboratory focused on melanoma research and cell signaling. Currently, she is Director of Medical Strategy, Oncology, at Physicians’ Education Resource, New Jersey, and adjunct faculty in the Department of Pharmacology and Toxicology, Rutgers, The State University of New Jersey. Dr. Cohen-Solal graduated from Paris University, France, and completed her postdoctoral training at Ernest Mario School of Pharmacy, Rutgers. Dr. Cohen-Solal received several awards including a Research Scholar Grant from the American Cancer Society and awards from the New Jersey Commission on Cancer Research and the Melanoma Research Foundation. Dr. Cohen-Solal’s breakthroughs involve the identification of a new type of receptor in the genesis of melanoma, the disruption of natural tumor suppressive mechanisms in melanoma development and progression, as well as the role of oncogenic signaling in immune escape mechanisms.